English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113648/144635 (79%)
Visitors : 51638172      Online Users : 497
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    政大機構典藏 > 商學院 > 財務管理學系 > 學位論文 >  Item 140.119/34055
    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/34055


    Title: 創新能力對台灣及美國生技產業公司財務績效的影響
    The impact of innovation on firm`s financial performance of biotechnology industry in Taiwan and in US
    Authors: 唐惠萍
    Tang, Hui-Ping
    Contributors: 顏錫銘
    Yen, Simon H.
    唐惠萍
    Tang, Hui-Ping
    Keywords: 生技產業
    創新
    經營績效
    Biotechnology
    Innovation
    Performance
    Date: 2006
    Issue Date: 2009-09-17 19:16:55 (UTC+8)
    Abstract: 本研究主要目的是驗證台灣生技公司的創新能力對公司績效有無正
    面顯著影響,並且與美國市場的結果做比較。希望藉由證明創新能力能對
    公司績效有貢獻並能增加有利的投資機會使投資人對此新興產業的公司
    更有信心願意投入更多資金,以解決生技公司普遍研發經費和資金不足的
    困擾。關於公司績效的衡量指標,我們選取了與市場價值相關的績效指標
    Tobin’s q 和以會計帳面盈餘為基礎的績效指標資產報酬率(ROA);創新能
    力則以公司的研發密集度和專利數目作為衡量的代理變數。雖然過去有很
    多研究發現企業的創新能力對公司績效有顯著的正面影響,但是關於台灣
    市場的相關研究卻很少。本研究針對台灣生技產業探討此結論是否同樣成
    立,並與世界生技產業領導地位美國的結果做比較。
    研究結果發現:美國生技公司對於研發活動的投入明顯高於台灣的公
    司,但是在研究期間台灣生技公司有逐年增加對研發活動之投入的趨勢。
    整體來說,創新能力對於公司與市場價值相關的績效指標Tobin’s q 的
    影響在美國與台灣市場皆顯著正相關。而研發密集度對於公司以會計盈餘
    為基礎的績效指標之影響只在美國是顯著負相關,在台灣的影響不顯著。
    專利對於公司會計盈餘為基礎的績效在台灣與美國皆為顯著正相關。
    此外,因為每個國家及產業的現況、產業發展的階段、相關的法規不
    盡相同,而使得創新能力對公司財務績效的影響效果也有所差異。
    雖然對創新的投入可能暫時會對會計盈餘有負面影響,但是創新能力
    卻能為公司帶來更多有利的投資機會及提昇公司與市場價值相關的財務
    績效。因此台灣投資人不應該短視近利,要對有良好創新能力的公司有信
    心進而願意投資更多資金,如此公司募得足夠資金去提升其創新能力後,
    將能在市場上更有競爭力轉而回報給投資人更好的報酬。
    另一方面政府也應更積極改進和簡化對於這個新興產業和無形資產相
    關的法令規章。在健全且有效率的法規環境保護之下,公司將能更順利發
    展其創新能力,並能更有效率的將研發結果商品化及上市。如此,台灣生
    技產業的競爭力將能逐漸提升。
    The purpose of this study is to prove that firm’s innovation ability has a significantly
    positive effect on firm’s performance in Taiwan biotechnology and compare the
    results to those in US biotechnology industry. Through this study, we want to show
    investors that firm’s innovation ability can contribute to firm’s financial performance
    and increase profitable investment opportunities. Then investors can be more
    confident that firm’s innovation ability can contribute to financial performance and
    bring more profitable investment opportunities. Therefore, investors would be willing
    to invest more capital in this industry and firms can have enough capital to do R&D
    and develop innovation abilities. Tobin’s q and ROA are used to represent the
    market-based performance and accounting-based performance respectively. As for the
    innovation, we adopt R&D intensity and the number of patents as the proxy variables.
    Although previous studies prove that innovation has a positive effect on firm’s
    performance, fewer of them focus on such relationship in Taiwan biotechnology
    industry. This study fills the gap by providing empirical results to examine if this
    relationship is held in biotechnology industry in Taiwan.
    The empirical results show that US biotechnology firms place significantly more
    emphasis on R&D investment than Taiwan firms do but Taiwan firms tend to invest
    more and more in R&D during the research period. As a whole, innovation has a
    significant and positive effect on Tobin’s q in Taiwan and in US, and patent also has
    significant and positive effect on Tobin’s q in both regions. However, R&D intensity
    is negatively related to ROA only significant in US. Patent is significantly positive
    related to ROA in Taiwan and in US.
    In addition, the impacts of innovation on firm’s performance vary in different
    countries and industries because of different development stages, degree of
    competition and related regulations and so on.
    Reference: 1. 生物技術產業年鑑2006,民國95 年,經濟部出版
    2. 林順陽,民國94 年,製藥產業研發支出、非財務性指標與公司績
    效之關聯-以原料藥產業為例,國立中正大學會計資訊科技研究
    所碩士論文
    3. 高文惠,民國93 年,台灣醫療生技實驗室相關法規管理制度之探
    討,「跨領域科技管理研習班」國內受訓心得報告
    4. 黃德舜,1998,企業財務分析-企業價值的創造與評估,華泰出

    5. 陳俊瑋,民國93 年,台灣生物科技產業研發績效評估之研究,國
    立中山大學國際高階經營碩士學程碩士在職專班碩士論文
    6. 郭宏男,探討智慧資本與傳統產業經營績效之關聯性研究,第五
    屆兩岸產業發展與經營管理研討會
    7. 楊旻翰,民國89 年,台灣生技產業前景及各國發展模式分析,國
    立中央大學企業管理研究所碩士論文
    124
    English Reference
    1. Archibugi, Daniele and Mario Pianta, 1996, Measuring technological through
    patents and innovation surveys, Technovation 16(9), 451- 468.
    2. Ashton, W. Bradford and Rajat K. Sen, 1998, Using Patent Information in
    Technology Business Planning-Ⅰ, Research Technology Management, 42-46
    3. Bae, Sung C. and Dongnyoung Kim, 2003, The Effect of R&D Investments on
    Market Value of Firms Evidence from the U.S., Germany, and Japan,
    Multinational Business Review 11(3).
    4. Bharadwaj, Anandhi S. and Sundar G. Bharadwaj and Benn R. Konsynski, 1999,
    Information Technology Effects on Firm Performance a Measured by Tobin`s q,
    Management Science 45, 1008-1024.
    5. Boer, Peter F., 1994, Linking R&D to growth and shareholder value, Research &
    Technology Management May-June, 16-22.
    6. Bowen, Howard R., 1997, Investment in Learning: The Individual and Social
    Value of American Higher Education. Baltimore, MD. Johns Hopkins University
    Press.
    7. Chan, Han S. and John D. Martin and John W. Kensinger, 1990, Corporate
    research and development expenditures and share value, Journal of Financial
    Economics 26 August, 255-276.
    8. Chang, Joseph, 2001, Innovation drives competition in specialty chemicals
    industry, Chemical Market Reporter 260(17).
    9. Chauvin, Kevin W. and Mark Hirschey, 1993, Advertising, R&D expenditures and
    the market value of the firm, Financial Management 22, 128-140.
    10. Chung, Kee H. and Peter Wright and Charlie Charoenwong, 1998, Investment
    opportunities and market reaction to capital expenditure decisions, Journal of
    Banking and Finance 22, 41-60.
    125
    11. Cockburn, Iain and Zvi Griliches, 1998, Industry Effects and Appropriability
    Measures in the Stock Market`s Valuation of R&D and Patents, The American
    Economic Review 78(2), 419- 423.
    12. Erickson, G.ary and Jacobson Robert, 1992, Gaining comparative advantage
    through discretionary experience: The returns to R&D and advertising,
    Management Science 38(9), 1264-1279.
    13. Gerald, Gay D. and Jouahn Nam,1998, The underinvestment problem and
    corporate derivatives use, Financial Management 27(4), 53-69.
    14. Grant, Robert M.,1995, Contemporary strategy analysis: Concepts, technologies,
    applications, Boston, MA: Blackwell Business.
    15. Hall, Bronwyn H., 1993,The stock market’s valuation of R&D investment during
    the 1980’s, American Economic Review 83, 259-264.
    16. Hall, Linda A. and Sharmistha Bagchi-Sen, 2002, A study of R&D, innovation,
    and business performance in the Canadian biotechnology industry, Technovation
    22, 231-244.
    17. Henderson, Rebecca, Adam, Jaffe and Manuel, Trajtenberg, 1998, Universities as
    a Source of Commercial Technology: A Detailed Analysis of University Patenting,
    1965–1988, The Review of Economics and Statistics 80,119–127.
    18. Hitt, Michael A., Ireland R. Duane, Robert E. Hoskisson, 1995, Strategic
    management: competitiveness and globalization, New York: West publication Inc.
    19. Hitt, Michael A., Robert E. Hoskisson, Hicheon Kim, 1997, International
    diversification: Effects on innovation and firm performance in product-diversified
    firms, Academy of Management Journal, 40, 767-798.
    20. Huselid, Mark ,Susan E. Jackson, Randall S. Schuler, 1997, Technological and
    strategic human resource management effectiveness as determinants of firm
    performance, Academy of Management Journal 40(2),171-188.
    126
    21. Jonathan P O`Brien, 2003, The capital structure implications of pursuing a strategy
    of innovation, Strategic Management Journal 24(5).
    22. Keats, Barbara W.and Hitt A. Michael, 1988, A Causal Model of Linkages among
    Environmental Dimensions, Macro Organizational Characteristics, and
    Performance, Academy of Management Journal 31(3), 570-598.
    23. Lee, Jooh and Shim Eunsup, 2001, Moderating effects of R&D on corporate
    growth in U.S. and Japanese hi-tech industries: An empirical study, The Journal of
    High Technology Management Research 6(2), 179-191.
    24. Long, William F. and David J.Ravenscraft, 1993, LBO’s debt and R&D intensity,
    Strategic Management Journal 14, 119-135.
    25. Luís Cabral, 1995,Sunk Costs, Firm Size and Firm Growth, The Journal of
    Industrial Economics 43(2), 161-172.
    26. McConnell, John J. and Henri Servaes, 1995, Equity ownership and the two faces
    of debt, Journal of Financial Economics 39, 131-157.
    27. Megna, Pamela and Mark Klock,1993, The impact of intangible capital on Tobin’s
    q in the semiconductor industry, The American Economic Review 83(2).
    28. Megna, Pamela and Klock Mark, 2000, Measuring and valuing intangible capital
    in the wireless communications industry, The Quarterly Review of Economics and
    Finance 40, 519-532
    29. Porter, E. Michael, 1980, Competitive Strategy: Techniques for Analyzing
    Industries and Competitors, New York, NY: Free Press
    30. Rolf, Banz W., 1981, The relationship between return and market value of
    common stocks, Journal of Financial Economics 9, 3-18.
    31. Reisch,Marc S., and Alexander H. Tullo, 2006, 2006 Year in Review-Calm
    weather and fairly stable energy prices contributed to solid industry profits,
    Chemical& Engineering News, 84(51), 30-35.
    127
    32. Szewczyk, H.Samuel, George P. Tsetsekos, Zaher Zantout, 1996, The valuation of
    corporate R&D expenditures: evidence from investment opportunities and free
    cash flow, Financial Management 25, 105-110.
    33. Sveikauskas, Leo, 1986, The contribution Of R&D to productivity growth,
    Monthly Labor Review 108, 6-21.
    34. Tassey, Gregory, 1983, Competitive strategies and performance in
    technology-based industries, Journal of Economic Business 35, 21-40.
    35. Tsai, Shih-Chuan, 2001, Valuation of R&D and Advertising Expenditures, Journal
    of Contemporary Accounting 2(1).
    36. Watanabe, Chihiro , Kakoto T., Akira N., Takashi T., Charla G.B., November 2000,
    Technology spillover as complement for high-level R&D intensity in
    pharmaceutical industry, Technovation 22,245-258.
    37. Wolff, George, 2001, The Biotech Investor’s Bible, John Wiely & Sons, Inc.
    38. Zvi Griliches, 1990, Patent Statistics as Economic Indicators:A survey, Journal of
    Economic Literature 28(4), 1661-1707.
    Description: 碩士
    國立政治大學
    財務管理研究所
    93357009
    95
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0093357009
    Data Type: thesis
    Appears in Collections:[財務管理學系] 學位論文

    Files in This Item:

    File Description SizeFormat
    35700901.pdf69KbAdobe PDF2791View/Open
    35700902.pdf69KbAdobe PDF2782View/Open
    35700903.pdf119KbAdobe PDF2925View/Open
    35700904.pdf67KbAdobe PDF21060View/Open
    35700905.pdf162KbAdobe PDF2822View/Open
    35700906.pdf173KbAdobe PDF21648View/Open
    35700907.pdf123KbAdobe PDF22832View/Open
    35700908.pdf166KbAdobe PDF2888View/Open
    35700909.pdf263KbAdobe PDF21244View/Open
    35700910.pdf64KbAdobe PDF2640View/Open
    35700911.pdf324KbAdobe PDF22343View/Open
    35700912.pdf159KbAdobe PDF21349View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback